There is a well-established relationship between plasma concentrations of digoxin (PDC's) and therapeutic and toxic efJects. 
Empirical digitalizing and maintenance doses of digoxin have been relied upon traditionaIly.l However, widespread use of this drug has resulted in rates of toxicity that approach 20% of hospitalized patients taking the drug. 18 High mortality figures have also been reported. 15 There may be a significant incidence of "underdigitalization" as weIl. 2 The elevation of digoxin t Patient studied in wards.
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t Rheumatic heart disease. §Arteriosclerotic heart disease.
IIPrimary pulmonary hypertension.
1fCardiomyopathy.
#Congenital heart disease. plasma concentrations and slowing of urinary excretion of the drug in patients with impaired renal function and in anephric patients compared with those with normal renal function have been clearly shown. 3 • 5, 7 The usefulness of an educational pro gram in digitalis therapy in reducing intoxication has also been clearly shown. 16 The mathematical analysis of digitalis kinetics in patients with normal and impaired renal function 7 , 8 and a study of factors affecting endogenous creatinine clearance 9 , 10 (which is used as a measure of renal function) have led to an improved method of digoxin therapyll and computer- reported good correlation (r = 0.86) between computed body glycoside levels and measured serum digoxin concentration in 70 patients; however, despite the high correlation coefficient there was considerable scatter of points and a large amount of unexplained variance. Recently, Peck and associates 17 reported a randomized, prospective clinical trial comparing performance of physicians in their use of digoxin with and without computer assistance. Their results indicated that only 17.6% of the variance of measured serum digoxin concentrations was accounted for by the computer-predicted serum digoxin concentrations and only 2% of the variance of the measured serum digoxin concentrations was accounted for by the physieianpredicted serum digoxin concentrations. We report here a study in which plasma digoxin concentrations, measured in cardiac patients, were correlated with all readily measured parameters such as serum creatinine concentration, urinary excretion rate of ereatinine, dose of digoxin, body weight, age, and height-all at onee, in various eombinations, and individually. The purpose was to estimate how accurately one could prediet plasma digoxin concentration in a given patient from information on all the above parameters-when the correlation data were based on a panel of patients.
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Materials and methods
The subjects were 25 patients, 13 males and 12 females. Nineteen were studied on Plasma digoxin concentration (ng/ml). Multiple correlation coefficient, r 0.586 and der of the blood was treated with citrate, centrifuged as rapidly as possible, and kept in the frozen state until the digoxin concentration of the plasma was determined by the radioimmunoassay method of Stoll and associates. 2o The 24 hour urine sampIe was also assayed for creatinine in the same laboratory. Those patients studied on 2 consecutive days received their usual dose of digoxin about 7 A.M. on day 2, immediately after taking the blood sampIe. Urine was collected again from 10 A.M. on day 2 to 10 A.M. on day 3, and a second blood sampIe was taken at 7 A.M. on day 3 for serum creatinine and digoxin determinations.
When patients were studied on the wards, dosing with digoxin was at 8 A.M., urine was collected from 8 A.M. on day 1 to 8 A.M. on day 2, and blood for serum creatinine and digoxin concentrations was taken 8 hours after dosing (about 4 P.M.). Four of the 7 patients studied on the wards were studied for 2 consecutive days. The serum and urine of ward patients were analyzed for creatinine in the Clinical Pathology Laboratory of University Hospital. All digoxin determinations were made by the same laboratory technician in the laboratory of the senior author.
Sex, body weight, height, age, daily dose of digoxin, and dia gnosis of each patient are given in Table 1 .
The consistency of our data with that reported by others was checked in two different ways. First, the 95% confidence intervals of average plasma digoxin concentrations ( PDC ) for patients taking both 0.125 and 0.25 mg of digoxin per day in our study were compared with the line values predicted from a plot of average serum or plasma digoxin concentrations against daily dose of digoxin based on data available in the literature. 13 ,19 Second, the slopes and intercepts of log-log plots of creatinine clearance (ml/min./1.73 m 2 body surface area) against serum creatinine concentration (mg/l00 ml) from the 48 sets of data in our study were compared with similar slopes and intercepts available in the literature.
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Results
Values of urinary excretion rate of creatinine, serum creatinine concentration, and PDC for each day each patient was studied are shown in Table 1 . There are 48 sets of data for the 48 patient days. These results were analyzed in several ways.
Multiple linear regression. A multiple linear regression was performed with a suitable pro gram on the IBM 360/65 digital computer. The dependent variable was PDC. The independent variables were dose of digoxin, serum creatinine concentration, reciprocal of body weight,2 reciprocal of urinary excretion rate of creatinine," age, and height. Results are shown in Table 11 .
"See Appendix. A multiple correlation coefficient between one variable and a set of other variables is denned to be the maximum correlation between the one variable and a linear combination of the other variables. 14 Table II indicates that the multiple correlation coefficient ( r ) in this case was 0.586. The value of 100 r 2 gives the percentage of the total variance of the dependent variable, which is accounted for by the linear combination of the other variables. In this case the value of 100 r 2 was 34.3; hence, only 34.4% of the total variance of the PDC's was accounted for by the 6 independent variables. Consequently, ab out two thirds of the variance of the measured PDC' s is not accounted for by the dose of digoxin, serum creatinine concentration, reciprocal of body weight, reciprocal of urinary excretion rate of creatinine, age, and height associated with each digoxin concentration. The results in Table II (Table III) . Surprisingly, the correlation of excretion rate of creatinine with height gave a reasonably high correlation coefficient (r = 0.516). Because of the high correlation between body surface area and body weight, the correlation of excretion rate of creatinine with body weight (r = 0.458) had a similar "r" value to the correlation of excretion rate of creatinine with body surface area (r = 0.461). This suggests that for adults, correcting creatinine cIearance to that of a 70 kg man would be essentially as good as correcting Table III confirmed the results obtained in the multiple linear regression. Only the correlation of PDC with dose of digoxin and of PDC with serum creatinine concentration accounted for any appreciable percentage of the variance of the PDC's, but the 100 r 2 va lues were only 15.6% and 10.6%, respectively. Owing to the preceding results, the two correlations shown at the top of Table IV were performed. First, the PDC was correlated with the pro du ce of the ,ug/kg dose of digoxin and the serum creatinine concentration. 3 Second, the PDC was correlated with the quotient of the,ug/kg dose of digoxin and the creatinine clearance."
To justify the pooling of all the data, similar correlations were performed with the ward data alone (N = 11), the Clinical Research Center data alone (N = 37), data from fern ales only (N = 22) , and data from males only (N = 26). In each of these correlations the intercept was not significantly different from zero. For each correlation the slope for ward data was ·See Appendix. not significantly different from the slope for Clinical Fesearch Center data; the slope for females was not significantly different from the slope for males. Fig. 1 shows a plot of the PDC against the product of the ,ug/kg dose of digoxin and the serum creatinine concentration for the pooled data. The r value is 0.562; hence 100 r 2 = 31.6. Thus the product of the ,ug/ kg and the serum creatinine concentration accounts for 31.6% of the variance of the PDC's. The latter is only slightly less than the 34.3% accounted for by 6 variables in the multiple linear regression. Since the intercept of 0.17 in Fig. 1 is not significantly different from zero, and theory would suggest that the line should go through the 0,0 point, the least squares line forced through the origin was calculated; this line has the equation y = 0.19 x rather than the equationy = 0.17 + 0.154 x for the line shown in Fig. 1 . If one rounds off the 0.19 to 0.2, then a practical guide is that the plasma digoxin concentration in ng/ml is given by one fifth of the product of the ,ug/kg dose of digoxin and the serum creatinine concentration in mg/100 ml. However, with the wide scatter evident in Fig. 1 , the predictability of such a formula for the individual patient is ob- x (r = 0.970). Thus 94% of the variance of the average PDC's is accounted for by the differences in daily doses of digoxin. The intercept of 0.10 was not significantly different from zero. Also, theory indicates that the digoxin level should equal zero when the dose is zero. Hence the least squares line forced through the origin was calculated; this line has the equation: y = 3.4 x. This is the line drawn through the points in Fig. 2 . Thus, the average PDC's of panels of cardiac patients is weIl estimated by simply multiplying the daily dose of digoxin (expressed as mg/ day) by 3.4. The bars in Fig. 2 mark off ± 1 S.D. The 95% of CI of an individual patient's PDC would be more than 1.96 times as long as these bars, since the student t value has an asymptote of 1.96. Hence, although the graph and equations in Fig. 2 are useful for predicting average PDC's of panels of cardiac patients, they are of little or no use for predicting the PDC of an individual patient.
Effers~eG was the first to show that the logarithm of the endogenous 24 hOUf creatinine clearance was linearly related to the logarithm of the serum creatinine concentration over a broad range, and that the slope of the line was greater than the value of unity expected for a simple reciprocal relations hip between clearance and serum concentration. The intercepts of such plots are different for males and females, and this is most probably due to the differences in ratio of muscle mass/ body weight for the two sexes. Wagner 22 supported the results of Effers~e by showing that two other independent sets of data obeyed the same relationship. The last entry in Table IV of the Appendix shows the va lues of the slopes and intercepts of such log-log plots for the male and female data of the present study. These slopes and intercepts for males and fern ales in the present study were not significantly different from the corresponding values, calculated by Wagner/ 2 for 98 random female patients and 100 random male patients of the same hospital where the present study was performed. This indicates that the creatinine urinary excretion data and the serum creatinine concentration data collected in the present study were consistent with the data in the literature.
Discussion
Emphasis has been placed on per cent of variance of PDC's, which has been explained. It is enlightening to also consider the absolute amounts of explained and unexplained variance. Jelliffe and associates 12 had a total variance of 2.062 ng 2 /mP; they explained about 74% of the variance, but were Ieft with a variance of 0.538 that was unexplained. In the present report the total variance was 0.281 ng 2 /ml 2 ( calculated from PDC's in the last column of Table I) ; of this 34.3% was explained (Table II) , leaving a variance of 0.185 that was unexplained. Thus, the unexplained variance of Jelliffe, Buell, and Kalaba 12 was considerably greater than the unexplained variance in this report, even though the correlation coefficient reported by J elliffe and associates 12 was higher than the one reported in Table II of this report.
The results of the present study agree with the results of the study of Peck and associatesY They stated that input to their computer program consisted of the patient's sex, age, height, weight, his tory of digoxin use, a measure of renal function (serum creatinine, BUN, or measured creatinine cIearance), and physician-specified objectives. Such objectives incIuded the ... "desired" steady state serum concentration of digoxin ( SDC ), the time allowed to achieve steady state, and the time interval between maintenance doses. The output of the computer included aseries of predicted serum digoxin concentrations at various past and future times. They also measured SDC and correlated measured SDC with computer-predicted SDC. They reported an r value of 0.42 that was less than the r value of 0.586 obtained in the present study in the multiple linear regression of PDC with 6 independent variables. Their r value of 0.42 corresponds to a 100 r 2 value of 17.6%. Hence only 17.6% of the variance of their measured SDC's was accounted for by the computer-predicted SDC's.
The present study has shown that the predictability of plasma or serum digoxin in an individual patient from dose of digoxin, body weight, serum creatinine concentration, urinary excretion rate of creatinine, age, and height-where the basic correlation data is from a panel of cardiac patients-is extremely low. We agree with the conclusion of Peck and associates 17 that such results argue for serial measurement of PDC's in patients taking digoxin.
What causes the unexplained variance in the PDC's? The answer is purely speculative. Equation 2 in the Appendix suggests some of the factors that may be involved. The varying volume of distribution of digoxin, both interpatient and intrapatient, is undoubtedly a major cause of the unexplained variance of the PDC's. The tissue/plasma ratio of digoxin would be expected to vary widely from patient to patient, and this ratio will alter the apparent volume of distribution. Although some correction for variation in the rate constant of elimination of digoxin is made via creatinine clearance or serum creatinine concentration, there are still proportionality constants that vary from patient to patient as the plots reported by Wagner 22 illustrate. There may be variation in the fraction of each dose of digoxin that is absorbed, even when the digoxin is administered as one manufacturer's brand. This has not been studied, although wide variations have been shown 24 between different manufacturer's brands of digoxin.
All PDC's measured in our Clinical Research Center study were true minimum PDC' s since they were measured 24 hours after dosing and just before the next dose. In the ward study the PDC's were measured about 8 hours after dos es and hence were somewhat high er than the value at 24 hours would have been. This variation in sampling time, as has been done by other authors,'9 contributes to some of the unexplained variance of the PDC's. Drug interactions also undoubtedly cause variation in the PDC's. All patients in our study were taking several other drugs as weil as the digoxin. It has been reprHl ·d Z1 that other drugs can alter blood levt ' of digoxin. Intensive studies in individua. ')atients would most probably elucidate . 'me of the sources of the unexplained v .riance of the PDC's.
